These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 32367182)
1. Neuropathological findings in multiple system atrophy with cognitive impairment. Jellinger KA J Neural Transm (Vienna); 2020 Jul; 127(7):1031-1039. PubMed ID: 32367182 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Jellinger KA; Attems J Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624 [TBL] [Abstract][Full Text] [Related]
3. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Compta Y; Parkkinen L; O'Sullivan SS; Vandrovcova J; Holton JL; Collins C; Lashley T; Kallis C; Williams DR; de Silva R; Lees AJ; Revesz T Brain; 2011 May; 134(Pt 5):1493-1505. PubMed ID: 21596773 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Boeve BF; Silber MH; Ferman TJ; Lin SC; Benarroch EE; Schmeichel AM; Ahlskog JE; Caselli RJ; Jacobson S; Sabbagh M; Adler C; Woodruff B; Beach TG; Iranzo A; Gelpi E; Santamaria J; Tolosa E; Singer C; Mash DC; Luca C; Arnulf I; Duyckaerts C; Schenck CH; Mahowald MW; Dauvilliers Y; Graff-Radford NR; Wszolek ZK; Parisi JE; Dugger B; Murray ME; Dickson DW Sleep Med; 2013 Aug; 14(8):754-62. PubMed ID: 23474058 [TBL] [Abstract][Full Text] [Related]
5. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419 [TBL] [Abstract][Full Text] [Related]
6. A critical reappraisal of current staging of Lewy-related pathology in human brain. Jellinger KA Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic and genetic features of multiple system atrophy with Lewy body disease. Koga S; Li F; Zhao N; Roemer SF; Ferman TJ; Wernick AI; Walton RL; Faroqi AH; Graff-Radford NR; Cheshire WP; Ross OA; Dickson DW Brain Pathol; 2020 Jul; 30(4):766-778. PubMed ID: 32232888 [TBL] [Abstract][Full Text] [Related]
8. Neuropathological features of multiple system atrophy with cognitive impairment. Asi YT; Ling H; Ahmed Z; Lees AJ; Revesz T; Holton JL Mov Disord; 2014 Jun; 29(7):884-8. PubMed ID: 24752994 [TBL] [Abstract][Full Text] [Related]
9. Morphological substrates of mental dysfunction in Lewy body disease: an update. Jellinger KA J Neural Transm Suppl; 2000; 59():185-212. PubMed ID: 10961431 [TBL] [Abstract][Full Text] [Related]
10. Frequency of Comorbid Pathologies and Their Clinical Impact in Multiple System Atrophy. Sekiya H; Koga S; Murakami A; DeTure M; Ross OA; Uitti RJ; Cheshire WP; Wszolek ZK; Dickson DW Mov Disord; 2024 Feb; 39(2):380-390. PubMed ID: 37986699 [TBL] [Abstract][Full Text] [Related]
11. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Jellinger KA Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530 [TBL] [Abstract][Full Text] [Related]
12. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series. Geut H; Hepp DH; Foncke E; Berendse HW; Rozemuller JM; Huitinga I; van de Berg WDJ Acta Neuropathol Commun; 2020 Mar; 8(1):39. PubMed ID: 32216828 [TBL] [Abstract][Full Text] [Related]
13. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study. Yoon JH; Kim M; Moon SY; Yong SW; Hong JM J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880 [TBL] [Abstract][Full Text] [Related]
14. In vivo cortical diffusion imaging relates to Alzheimer's disease neuropathology. Torso M; Ridgway GR; Valotti M; Hardingham I; Chance SA; ; Alzheimers Res Ther; 2023 Oct; 15(1):165. PubMed ID: 37794477 [TBL] [Abstract][Full Text] [Related]
15. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Burton EJ; Barber R; Mukaetova-Ladinska EB; Robson J; Perry RH; Jaros E; Kalaria RN; O'Brien JT Brain; 2009 Jan; 132(Pt 1):195-203. PubMed ID: 19022858 [TBL] [Abstract][Full Text] [Related]
16. Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Molano J; Boeve B; Ferman T; Smith G; Parisi J; Dickson D; Knopman D; Graff-Radford N; Geda Y; Lucas J; Kantarci K; Shiung M; Jack C; Silber M; Pankratz VS; Petersen R Brain; 2010 Feb; 133(Pt 2):540-56. PubMed ID: 19889717 [TBL] [Abstract][Full Text] [Related]
17. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology. Ryman SG; Yutsis M; Tian L; Henderson VW; Montine TJ; Salmon DP; Galasko D; Poston KL J Alzheimers Dis; 2021; 80(3):1243-1256. PubMed ID: 33646154 [TBL] [Abstract][Full Text] [Related]
18. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Attems J; Jellinger KA Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases. Jellinger KA Neurodegener Dis; 2010; 7(1-3):112-5. PubMed ID: 20173339 [TBL] [Abstract][Full Text] [Related]